Medicus Sciences Acquisition Corp. (MSAC) Research
Medicus Sciences Acquisition Corp., founded in 2020 and headquartered in New York, New York, currently has no substantial independent business activities. Its main goal is to execute a business combination—such as a merger, stock exchange, asset purchase, or reorganization—with one or more enterprises. The company's strategic focus is on the healthcare industry, particularly the medical technology sector, seeking opportunities both domestically in the United States and around the world.
Market snapshot
- Symbol
- MSAC
- Price
- $10.17
- Day change
- +0.05%
- Market cap
- $100.4M
- P/E ratio
- 55.33x
- 52-week range
- 9.72-10.18
- Sector
- Financial Services
- Industry
- Shell Companies
Peer companies
- Atlantic Coastal Acquisition Corp. (ACAH)
- 26 Capital Acquisition Corp. (ADER)
- Crown Proptech Acquisitions (CPTK)
- Juniper II Corp. (JUN)
- Minority Equality Opportunities Acquisition Inc. (MEOA)
- Northern Star Investment Corp. II (NSTB)
- Patria Latin American Opportunity Acquisition Corp. (PLAO)
- RCF Acquisition Corp. (RCFA)
Open Medicus Sciences Acquisition Corp. (MSAC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.